Reported Friday, Decoy Therapeutics Enters Up To $21M Private Placement With Healthcare Investor At $5.91 Per Share To Advance Lead Asset Into Clinical Trials

Loading news article.

Reported Friday, Decoy Therapeutics Enters Up To $21M Private Placement With Healthcare Investor At $5.91 Per Share To Advance Lead Asset Into Clinical Trials | WAPE

Reported Friday, Decoy Therapeutics Enters Up To $21M Private Placement With Healthcare Investor At $5.91 Per Share To Advance Lead Asset Into Clinical Trials

Article summary

Related companies

Comments —